Warning on psychedelic drugs rollout
Psychiatrists flag concerns with the rollout of psychedelic drug treatments in Australia as a key US panel votes against supporting MDMA as a treatment for PTSD.
Psychiatrists flag concerns with the rollout of psychedelic drug treatments in Australia as a key US panel votes against supporting MDMA as a treatment for PTSD.
Leading food manufacturers may be subject to mandatory health star ratings as evidence accumulates that the industry is falling far short of federal government targets.
The nation’s health regulator has warned some doctors working for commercial telehealth clinics may be putting profit ahead of patient welfare, sidestepping obligations to provide safe care.
Drug companies will be required to include product warnings that antidepressant medication may cause long-lasting sexual dysfunction that could persist for years.
Top doctors have called for the introduction of a national register of healthcare worker suicides amid indications the true rate of doctors and nurses taking their own lives is higher than indicated.
Critical overloading that brought the South Australian hospital system to its knees could be soon replicated around the country.
A deal that paves the way for Australia’s biggest importation of psychedelic drugs has been struck by a charity pushing the new therapy.
Patients who have joint replacement surgery could be routinely discharged from hospital on the same day of their operation as NSW leads the country in instituting shorter stays in hospital.
Replica versions of Ozempic will be banned from being made in specialised pharmacies, as Labor moves to crack down on an unregulated drug market.
The crisis swamping public psychiatry services dealing with schizophrenic patients remains unremedied as early intervention services get millions.
Original URL: https://www.theaustralian.com.au/author/natasha-robinson/page/8